These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7931666)

  • 1. Cancer or inflammation? A Holy Grail for nuclear medicine.
    Larson SM
    J Nucl Med; 1994 Oct; 35(10):1653-5. PubMed ID: 7931666
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there a role for FDG PET imaging in the management of patients with sarcoidosis?
    Alavi A; Buchpiguel CA; Loessner A
    J Nucl Med; 1994 Oct; 35(10):1650-2. PubMed ID: 7931665
    [No Abstract]   [Full Text] [Related]  

  • 3. Uptake of fluorine-18-fluorodeoxyglucose in sarcoidosis.
    Lewis PJ; Salama A
    J Nucl Med; 1994 Oct; 35(10):1647-9. PubMed ID: 7931664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High fluorine-18 labeled deoxyglucose uptake in sarcoidosis.
    Yasuda S; Shohtsu A; Ide M; Takagi S; Ogawa J; Mitomi T; Suzuki Y
    Clin Nucl Med; 1996 Dec; 21(12):983-4. PubMed ID: 8957624
    [No Abstract]   [Full Text] [Related]  

  • 5. PET with fluorine-18 deoxyglucose for pancreatic disease.
    Klever P; Bares R; Fass J; Büll U; Schumpelick V
    Lancet; 1992 Nov; 340(8828):1158-9. PubMed ID: 1359226
    [No Abstract]   [Full Text] [Related]  

  • 6. [Usefulness of fluorine-18 fluoro-2-deoxyglucose positron emission tomography for diagnosis and therapy assessment of cardiac sarcoidosis].
    Ishida Y; Nakatani S; Tachibana T
    J Cardiol; 2000 Apr; 35(4):301-4. PubMed ID: 10791274
    [No Abstract]   [Full Text] [Related]  

  • 7. [67-Gallium citrate gammagraphy in the study of lymphomas].
    Ricart Y
    Rev Esp Med Nucl; 2002 Apr; 21(2):85-7. PubMed ID: 11879615
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of oncology protocol using fluorine-18-FDG: one center's experience.
    Cronin V; Galantowicz P; Nabi HA
    J Nucl Med Technol; 1997 Mar; 25(1):66-9. PubMed ID: 9239608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis of cancers by FDG-PET].
    Ichiya Y
    Fukuoka Igaku Zasshi; 1997 Jan; 88(1):7-10. PubMed ID: 9091463
    [No Abstract]   [Full Text] [Related]  

  • 10. PET cancer evaluations with FDG.
    Hawkins RA; Hoh C; Dahlbom M; Choi Y; Glaspy J; Tse N; Slamon D; Chen B; Messa C; Maddahi J
    J Nucl Med; 1991 Aug; 32(8):1555-8. PubMed ID: 1869978
    [No Abstract]   [Full Text] [Related]  

  • 11. Positron emission tomography, bronchogenic carcinoma, and the adrenals.
    Lamki LM
    AJR Am J Roentgenol; 1997 May; 168(5):1361-2. PubMed ID: 9129445
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there a future for PET in oncology?
    Price P
    Eur J Nucl Med; 1997 Jun; 24(6):587-9. PubMed ID: 9235296
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experimental study for cancer diagnosis with 18FDG: differential diagnosis of inflammation from malignant tumor].
    Fukuda H; Yoshioka S; Watanuki S; Kiyosawa M; Sato T; Matsuzawa T; Takahashi T; Ido T
    Kaku Igaku; 1983 Sep; 20(8):1189-92. PubMed ID: 6672371
    [No Abstract]   [Full Text] [Related]  

  • 14. SUV: standard uptake or silly useless value?
    Keyes JW
    J Nucl Med; 1995 Oct; 36(10):1836-9. PubMed ID: 7562051
    [No Abstract]   [Full Text] [Related]  

  • 15. Tracer feasibility for monitoring tumor radiotherapy: a quadruple tracer study with fluorine-18-fluorodeoxyglucose or fluorine-18-fluorodeoxyuridine, L-[methyl-14C]methionine, [6-3H]thymidine, and gallium-67.
    Kubota K; Ishiwata K; Kubota R; Yamada S; Tada M; Sato T; Ido T
    J Nucl Med; 1991 Nov; 32(11):2118-23. PubMed ID: 1834814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomographic oncology.
    Lawson MA
    West J Med; 1994 Oct; 161(4):411-2. PubMed ID: 7817554
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluorodeoxyglucose (FDG) and tumour metabolism.
    Van Wyngaarden KE; Pauwels EK
    Nucl Med Commun; 1995 Dec; 16(12):987-9. PubMed ID: 8719978
    [No Abstract]   [Full Text] [Related]  

  • 18. Tissue characterization in nuclear oncology: its time has come.
    Lamki LM
    J Nucl Med; 1995 Feb; 36(2):207-10. PubMed ID: 7830115
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative positron emission tomography imaging to measure tumor response to therapy: what is the best method?
    Mankoff DA; Muzi M; Krohn KA
    Mol Imaging Biol; 2003; 5(5):281-5. PubMed ID: 14630508
    [No Abstract]   [Full Text] [Related]  

  • 20. [Use of positron-emission tomography in oncology].
    Strauss LG; Kabelitz D; Kremer B; Lode H; Meinertz T; Sauerbruch T; Sterry W
    Dtsch Med Wochenschr; 1996 Feb; 121(7):207-9. PubMed ID: 8681765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.